Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain

Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain

Introduction: We have different treatment alternatives for relapsing-remitting multiple sclerosis–RRMS–within the so-called platform drugs. It would be desirable to know the ideal drug for each patient. Real clinical practice studies provide us with data on drug efficacy in the medium and long term,...

Full description

Bibliographic Details
Main Authors: Lamberto Landete, Francisco Pérez-Miralles, Sara García, Antonio Belenguer, Francisco Gascón, Jose Andres Domínguez, María Carcelén-Gadea, Carlos Quintanilla-Bordás, Laura Navarro, Laura Gabaldón, Bonaventura Casanova
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Neurology
Subjects:
teriflunomide
MS therapy
real world evidence (RWE)
cohort analysis
multicentric study
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.727586/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.727586/full

Similar Items